4DMedical (ASX:4DX) said it renewed its contract with the University of Michigan Medical Center for another three years from July 1 to June 30, 2028, for a total value of around AU$155,000, according to a Friday Australian bourse filing.
University of Michigan clinicians and researchers will have access to 4DMedical's full suite of structural lung analysis applications via the Enterprise Core Computing platform.
The firm also reported the award of AU$1.1 million in non-dilutive cash funding under the first round of Australia's Economic Accelerator Innovate grant program for a project led by the University of Adelaide with 4DMedical as one of the partners.
The project will seek to develop AI-derived functional biomarkers to enhance respiratory disease diagnosis and treatment.
Its shares jumped 4% in recent trading on Friday.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。